Ilmarinen Mutual Pension Insurance Co Has $3.09 Million Position in Agilent Technologies, Inc. (NYSE:A)

Ilmarinen Mutual Pension Insurance Co lifted its position in Agilent Technologies, Inc. (NYSE:A) by 53.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,000 shares of the medical research company’s stock after acquiring an additional 8,000 shares during the period. Ilmarinen Mutual Pension Insurance Co’s holdings in Agilent Technologies were worth $3,090,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. CKW Financial Group grew its stake in Agilent Technologies by 114.9% in the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock valued at $25,000 after acquiring an additional 100 shares during the period. Global X Japan Co. Ltd. grew its position in shares of Agilent Technologies by 161.1% in the 4th quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 116 shares during the period. Lee Danner & Bass Inc. bought a new stake in Agilent Technologies during the 4th quarter worth approximately $29,000. Hanson & Doremus Investment Management raised its holdings in Agilent Technologies by 66.5% during the 4th quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company’s stock worth $35,000 after buying an additional 105 shares during the period. Finally, OFI Invest Asset Management bought a new position in Agilent Technologies in the fourth quarter valued at approximately $37,000.

Analyst Ratings Changes

A has been the subject of several research reports. Barclays raised shares of Agilent Technologies from an “underweight” rating to an “equal weight” rating and increased their price objective for the stock from $135.00 to $145.00 in a research report on Monday, February 10th. Bank of America dropped their price target on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a research note on Friday, December 13th. Wells Fargo & Company decreased their price objective on Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a report on Monday, December 9th. Robert W. Baird cut their target price on Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating on the stock in a research note on Thursday, February 27th. Finally, StockNews.com raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Tuesday, December 24th. Seven investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $150.83.

Insiders Place Their Bets

In other Agilent Technologies news, Director Daniel K. Podolsky sold 1,819 shares of Agilent Technologies stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $116.46, for a total value of $211,840.74. Following the completion of the sale, the director now owns 35,737 shares in the company, valued at $4,161,931.02. The trade was a 4.84 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Padraig Mcdonnell sold 1,911 shares of the business’s stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the sale, the chief executive officer now directly owns 39,652 shares of the company’s stock, valued at $5,947,800. This represents a 4.60 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 5,638 shares of company stock worth $731,229 over the last three months.

Agilent Technologies Stock Down 6.1 %

Agilent Technologies stock opened at $102.97 on Friday. Agilent Technologies, Inc. has a fifty-two week low of $102.85 and a fifty-two week high of $155.35. The firm has a market capitalization of $29.36 billion, a PE ratio of 23.67, a P/E/G ratio of 2.89 and a beta of 1.19. The company’s 50-day moving average is $130.34 and its 200-day moving average is $135.73. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.20 and a quick ratio of 1.66.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. The company had revenue of $1.68 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.57 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st will be issued a $0.248 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.99 annualized dividend and a yield of 0.96%. Agilent Technologies’s dividend payout ratio is currently 22.76%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.